Endocrine signaling research
GHRP-2
Lyophilized endocrine-signaling research peptide for systems review
GHRP-2 is a growth hormone secretagogue research peptide studied around ghrelin-receptor activity and GH-release models.
Support can confirm any currently available COAs or batch documentation for this product.
Request available documentsConfirm an optional email signup to receive a single-use 10% welcome code.
Get catalog updatesFor laboratory research use only. Not for human or veterinary use. Not intended to diagnose, treat, cure, mitigate, or prevent disease.
Keep sealed, cold, dry, and protected from heat swings. Confirm product-specific storage on arrival.
Packed for transit stability with order support available for warm-weather routes.
Batch-linked certificate support is available through the documentation desk.
연구 맥락
GHRP-2 연구 프로필
GHRP-2 is a synthetic growth hormone secretagogue studied through the ghrelin receptor pathway. Research examines GH-release magnitude and timing, endocrine-response markers, receptor pharmacology, appetite-related observations, and comparisons with GHRP-6, ipamorelin, or GHRH analogs. Its experimental profile is not identical to ipamorelin, which is often studied for greater selectivity, or GHRP-6, which is frequently associated with stronger appetite-pathway observations. GHRP-2 is useful as an established secretagogue comparator in GH-axis work. Study design should separate direct GHS-R signaling from GHRH-receptor activity and should not translate endocrine findings into personal-use or treatment recommendations.
제안된 기전
A synthetic agonist at GHS-R1a. It stimulates pituitary growth-hormone release and also engages hypothalamic ghrelin-related pathways; endocrine selectivity is lower than that reported for ipamorelin.
연구에서 보고된 효과
- Human studies reported marked acute GH release, with responses influenced by dose, age, nutrition, and concurrent GHRH signaling.
- Studies also reported appetite-related effects and changes in ACTH, cortisol, or prolactin under some conditions.
- Repeated exposure can produce altered responsiveness or desensitization depending on the experimental schedule.
일반적인 연구 평가변수
GHS-R potency, GH peak and area under the curve, ACTH, cortisol, prolactin, food intake, glucose, receptor desensitization, and synergy experiments with GHRH.
근거와 한계
Human endocrine pharmacology and preclinical evidence exist, but long-term effects and catalog-product equivalence are not established.
External reading
Literature for context—not product proof.
Third-party sources describe their own research materials and methods. They do not validate a specific Azure catalog batch.
Support and documentation
Questions about this product?
What documentation can I request before ordering?
Before ordering, contact support with the product name, selected format, andu2014if availableu2014an order or batch reference to request available batch-linked documentation.
What should I confirm before ordering?
Compare the product name, listed amount, physical form, storage note, price, and documentation route. When the order arrives, match the product and lot or batch reference to the order record and available documentation.